147 related articles for article (PubMed ID: 27488596)
1. TDP-43 pathology and cognition in ALS: A prospective clinicopathologic correlation study.
Prudlo J; König J; Schuster C; Kasper E; Büttner A; Teipel S; Neumann M
Neurology; 2016 Sep; 87(10):1019-23. PubMed ID: 27488596
[TBL] [Abstract][Full Text] [Related]
2. Clinical Significance of TDP-43 Neuropathology in Amyotrophic Lateral Sclerosis.
Cykowski MD; Powell SZ; Peterson LE; Appel JW; Rivera AL; Takei H; Chang E; Appel SH
J Neuropathol Exp Neurol; 2017 May; 76(5):402-413. PubMed ID: 28521037
[TBL] [Abstract][Full Text] [Related]
3. TDP-43 in the hypoglossal nucleus identifies amyotrophic lateral sclerosis in behavioral variant frontotemporal dementia.
Halliday GM; Kiernan MC; Kril JJ; Mito R; Masuda-Suzukake M; Hasegawa M; McCann H; Bartley L; Dobson-Stone C; Kwok JBJ; Hornberger M; Hodges JR; Tan RH
J Neurol Sci; 2016 Jul; 366():197-201. PubMed ID: 27288806
[TBL] [Abstract][Full Text] [Related]
4. Microglial activation and TDP-43 pathology correlate with executive dysfunction in amyotrophic lateral sclerosis.
Brettschneider J; Libon DJ; Toledo JB; Xie SX; McCluskey L; Elman L; Geser F; Lee VM; Grossman M; Trojanowski JQ
Acta Neuropathol; 2012 Mar; 123(3):395-407. PubMed ID: 22210083
[TBL] [Abstract][Full Text] [Related]
5. Pathological TDP-43 in parkinsonism-dementia complex and amyotrophic lateral sclerosis of Guam.
Geser F; Winton MJ; Kwong LK; Xu Y; Xie SX; Igaz LM; Garruto RM; Perl DP; Galasko D; Lee VM; Trojanowski JQ
Acta Neuropathol; 2008 Jan; 115(1):133-45. PubMed ID: 17713769
[TBL] [Abstract][Full Text] [Related]
6. Executive, language and fluency dysfunction are markers of localised TDP-43 cerebral pathology in non-demented ALS.
Gregory JM; McDade K; Bak TH; Pal S; Chandran S; Smith C; Abrahams S
J Neurol Neurosurg Psychiatry; 2020 Feb; 91(2):149-157. PubMed ID: 31515300
[TBL] [Abstract][Full Text] [Related]
7. The neuropathology of FTD associated With ALS.
Mackenzie IR
Alzheimer Dis Assoc Disord; 2007; 21(4):S44-9. PubMed ID: 18090423
[TBL] [Abstract][Full Text] [Related]
8. TDP-43 expression in mouse models of amyotrophic lateral sclerosis and spinal muscular atrophy.
Turner BJ; Bäumer D; Parkinson NJ; Scaber J; Ansorge O; Talbot K
BMC Neurosci; 2008 Oct; 9():104. PubMed ID: 18957104
[TBL] [Abstract][Full Text] [Related]
9. TDP-43 levels in the brain tissue of ALS cases with and without
Yang Y; Halliday GM; Kiernan MC; Tan RH
Neurology; 2019 Nov; 93(19):e1748-e1755. PubMed ID: 31619481
[TBL] [Abstract][Full Text] [Related]
10. Spinal cord extracts of amyotrophic lateral sclerosis spread TDP-43 pathology in cerebral organoids.
Tamaki Y; Ross JP; Alipour P; Castonguay CÉ; Li B; Catoire H; Rochefort D; Urushitani M; Takahashi R; Sonnen JA; Stifani S; Dion PA; Rouleau GA
PLoS Genet; 2023 Feb; 19(2):e1010606. PubMed ID: 36745687
[TBL] [Abstract][Full Text] [Related]
11. Induction of autophagy mitigates TDP-43 pathology and translational repression of neurofilament mRNAs in mouse models of ALS/FTD.
Kumar S; Phaneuf D; Cordeau P; Boutej H; Kriz J; Julien JP
Mol Neurodegener; 2021 Jan; 16(1):1. PubMed ID: 33413517
[TBL] [Abstract][Full Text] [Related]
12. Perfusion alterations converge with patterns of pathological spread in transactive response DNA-binding protein 43 proteinopathies.
Ferraro PM; Jester C; Olm CA; Placek K; Agosta F; Elman L; McCluskey L; Irwin DJ; Detre JA; Filippi M; Grossman M; McMillan CT
Neurobiol Aging; 2018 Aug; 68():85-92. PubMed ID: 29751289
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of brain and spinal cord inclusions, including dipeptide repeat proteins, in patients with the C9ORF72 hexanucleotide repeat expansion: a systematic neuropathological review.
Schipper LJ; Raaphorst J; Aronica E; Baas F; de Haan R; de Visser M; Troost D
Neuropathol Appl Neurobiol; 2016 Oct; 42(6):547-60. PubMed ID: 26373655
[TBL] [Abstract][Full Text] [Related]
14. Heterogeneity of cerebral TDP-43 pathology in sporadic amyotrophic lateral sclerosis: Evidence for clinico-pathologic subtypes.
Takeuchi R; Tada M; Shiga A; Toyoshima Y; Konno T; Sato T; Nozaki H; Kato T; Horie M; Shimizu H; Takebayashi H; Onodera O; Nishizawa M; Kakita A; Takahashi H
Acta Neuropathol Commun; 2016 Jun; 4(1):61. PubMed ID: 27338935
[TBL] [Abstract][Full Text] [Related]
15. In vitro prion-like behaviour of TDP-43 in ALS.
Smethurst P; Newcombe J; Troakes C; Simone R; Chen YR; Patani R; Sidle K
Neurobiol Dis; 2016 Dec; 96():236-247. PubMed ID: 27590623
[TBL] [Abstract][Full Text] [Related]
16. Primary lateral sclerosis and the amyotrophic lateral sclerosis-frontotemporal dementia spectrum.
Agarwal S; Highton-Williamson E; Caga J; Matamala JM; Dharmadasa T; Howells J; Zoing MC; Shibuya K; Geevasinga N; Vucic S; Hodges JR; Ahmed RM; Kiernan MC
J Neurol; 2018 Aug; 265(8):1819-1828. PubMed ID: 29868980
[TBL] [Abstract][Full Text] [Related]
17. Clinical and neuropathological features of ALS/FTD with TIA1 mutations.
Hirsch-Reinshagen V; Pottier C; Nicholson AM; Baker M; Hsiung GR; Krieger C; Sengdy P; Boylan KB; Dickson DW; Mesulam M; Weintraub S; Bigio E; Zinman L; Keith J; Rogaeva E; Zivkovic SA; Lacomis D; Taylor JP; Rademakers R; Mackenzie IRA
Acta Neuropathol Commun; 2017 Dec; 5(1):96. PubMed ID: 29216908
[TBL] [Abstract][Full Text] [Related]
18. Fast Progression in Amyotrophic Lateral Sclerosis Is Associated With Greater TDP-43 Burden in Spinal Cord.
Cathcart SJ; Appel SH; Peterson LE; Greene EP; Powell SZ; Arumanayagam AS; Rivera AL; Cykowski MD
J Neuropathol Exp Neurol; 2021 Sep; 80(8):754-763. PubMed ID: 34383907
[TBL] [Abstract][Full Text] [Related]
19. Pathological TDP-43 distinguishes sporadic amyotrophic lateral sclerosis from amyotrophic lateral sclerosis with SOD1 mutations.
Mackenzie IR; Bigio EH; Ince PG; Geser F; Neumann M; Cairns NJ; Kwong LK; Forman MS; Ravits J; Stewart H; Eisen A; McClusky L; Kretzschmar HA; Monoranu CM; Highley JR; Kirby J; Siddique T; Shaw PJ; Lee VM; Trojanowski JQ
Ann Neurol; 2007 May; 61(5):427-34. PubMed ID: 17469116
[TBL] [Abstract][Full Text] [Related]
20. Review: Prion-like mechanisms of transactive response DNA binding protein of 43 kDa (TDP-43) in amyotrophic lateral sclerosis (ALS).
Smethurst P; Sidle KC; Hardy J
Neuropathol Appl Neurobiol; 2015 Aug; 41(5):578-97. PubMed ID: 25487060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
